Shopping Cart 0
Cart Subtotal
USD 0

OriGene Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and markets genome research and diagnostic products. OriGene provides products such as qPCR reagents, transfection reagent, precisionshuttling kits, cDNA clones, HuSH shRNA, plasmid purification, siRNA, miRNA, proteins antibodies, IHC products, assays and human tissues, among others. The company provides services such asd gene synthesis, custom shRNA, custom cloning, custom protein service, antibody service, assay development and stable cell line development. It offers research in the areas of cancer biomarker research, pathology IHC, stem cell research, ion channels, protein kinase, and others. The company provides products and services to pharmaceutical and biotechnology companies and academic research institutes. OriGene is headquartered in Rockville, Maryland, the US.

OriGene Technologies Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OriGene Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OriGene Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 10

Asset Purchase 10

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For USD 16 Million 10

Venture Financing 12

OriGene Technologies Raises USD6.4 Million in Venture Financing 12

OriGene Technologies Raises Funds in Financing Round 13

OriGene Technologies Raises USD17 Million in Venture Financing 14

OriGene Technologies Raises USD0.2 Million in Venture Financing 15

OriGene Technologies Raises USD 21 Million In Series C Financing 16

Origene Technologies Raises USD 15 Million In Venture Financing 17

Partnerships 18

OriGene Technologies Enters into Contract with National Cancer Institute 18

Entia Biosciences Enters Into Co-Development Agreement With Biocheck 19

Licensing Agreements 20

Dako Enters into Licensing Agreement with OriGene Technologies 20

Asset Transactions 21

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For USD 16 Million 21

Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For USD 13.5 Million 23

Acquisition 24

OriGene Technologies Acquires Acris Antibodies 24

OriGene Technologies Inc-Key Competitors 25

OriGene Technologies Inc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OriGene Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8


List Of Table

List of Tables

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OriGene Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OriGene Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8

OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For USD 16 Million 10

OriGene Technologies Raises USD6.4 Million in Venture Financing 12

OriGene Technologies Raises Funds in Financing Round 13

OriGene Technologies Raises USD17 Million in Venture Financing 14

OriGene Technologies Raises USD0.2 Million in Venture Financing 15

OriGene Technologies Raises USD 21 Million In Series C Financing 16

Origene Technologies Raises USD 15 Million In Venture Financing 17

OriGene Technologies Enters into Contract with National Cancer Institute 18

Entia Biosciences Enters Into Co-Development Agreement With Biocheck 19

Dako Enters into Licensing Agreement with OriGene Technologies 20

Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For USD 16 Million 21

Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For USD 13.5 Million 23

OriGene Technologies Acquires Acris Antibodies 24

OriGene Technologies Inc, Key Competitors 25

OriGene Technologies Inc, Subsidiaries 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

OriGene Technologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.